6505--Radiopharmaceuticals PLUVICTO / LUTATHERA - Nuclear Med, IND

The Department of Veterans Affairs, VA Healthcare System, Network 10 Contracting Office intends to negotiate a sole source contract for a FDA approved radioactive therapy drug. The therapeutic effectiveness of this radioactive drug has changed standard patient care guidelines and now patients diagnosed with prostate cancer are recommended to have Lu177 PLUVICTO as a treatment option. Also needed is the purchase of the Lu177 LUTATHERA. • The contract will be for a one-year firm fixed price. • The vendor will be Novartis, Route 10, East Hanover, NJ, 07936. • The associated NAICS code for this is 325412. • The contract is for the supply of a new FDA approved radioactive therapy drug.